Medical Device Maker Flags Eight Flaws in Drug Infusion Products

CISA said the BD product vulnerabilities have a "low attack complexity" and that successful exploitation could allow a malicious actor to compromise sensitive data, hijack a session, modify firmware, and make changes to system configurations.